US 10648001
Method of treating mucopolysaccharidosis type I or II
granted A61KA61K35/407A61K38/465
Quick answer
US patent 10648001 (Method of treating mucopolysaccharidosis type I or II) held by Sangamo Therapeutics, Inc. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K35/407, A61K38/465, A61K38/47, A61K48/00